Skip to content

Pharma Petite Suisse

Active
Private limited companyfounded 2018active for 7 yearsBoondaalse Steenweg 312, 1050 Elsene, BelgiumKBO/BCE: BE 0715.975.212
Summary

Pharma Petite Suisse has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €42,146 and a net result of €80,315. Equity is growing by about 16% per year across the filed financial years. Its solvency ranks better than 17% of 12,724 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.2% (low).

Risk analysisFollow ReportCompare
Pharma Petite SuisseActiveChecked score 65/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
≈ €1.1mturnover 2025, estimated
Staff
2.3 FTE
Equity
€42,146
Profit
€80,315
Turnover estimated from the gross margin
Financial health
65 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.2%
Structure
2025 accounts 52 days early1 of 3 deeds summarised
Why 65raises riskEquity €42,146 (5.4% of total assets)Sector: Retail trade (NACE 47)lowers riskSize: 2.3 FTE, total assets €776,775Figures for financial year 2025 (filed 09-06-2026)Show the evidence

Checked score

Score 2025
65 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 43% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 30=
equity 5.4% of total assets
Liquidity 36-3
short-term debt 40.8% · cash 4.0%
Profitability 82+2
return on assets 10.3%
Bankruptcy probability, 12 months
1.2% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,263 companies, NACE 47, micro)
Last 24 months 11-2024: 1.7% 12-2024: 1.7%● unchanged vs 11-2024 01-2025: 1.7%● unchanged vs 12-2024 02-2025: 1.7%● unchanged vs 01-2025 03-2025: 1.6%▼ -0.1 percentage points vs 02-2025 04-2025: 1.6%● unchanged vs 03-2025 05-2025: 1.6%● unchanged vs 04-2025 06-2025: 1.7%▲ +0.1 percentage points vs 05-2025 07-2025: 1.8%▲ +0.1 percentage points vs 06-2025 08-2025: 2.5%▲ +0.7 percentage points vs 07-2025highest value 09-2025: 1.3%▼ -1.2 percentage points vs 08-2025 10-2025: 1.3%● unchanged vs 09-2025 11-2025: 1.3%● unchanged vs 10-2025 12-2025: 1.3%● unchanged vs 11-2025 01-2026: 1.3%● unchanged vs 12-2025 02-2026: 1.3%● unchanged vs 01-2026 03-2026: 1.3%● unchanged vs 02-2026 04-2026: 1.4%▲ +0.1 percentage points vs 03-2026 05-2026: 1.4%● unchanged vs 04-2026 06-2026: 1.5%▲ +0.1 percentage points vs 05-2026 07-2026: 1.3%▼ -0.2 percentage points vs 06-2026 08-2026: 1.3%● unchanged vs 07-2026 09-2026: 1.2%▼ -0.1 percentage points vs 08-2026lowest value 10-2026: 1.2%● unchanged vs 09-2026lowest value
Credit of up to €2,500 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.81, compared with 0.9 in 2024, below 1; short-term debt: 40.8% and cash: 4% of total assets), and 94.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 23% on solvency, 33% on liquidity, 74% on profitability and 42% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Equity €42,146 (5.4% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Size: 2.3 FTE, total assets €776,775
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 09-06-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 17% of 12724 sector peers (2025).
NBB · sector comparison
Position among 12724 sector peers
Solvency
better than 17%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
52 days early
2024
1 day early
2023
22 days late
2022
28 days late
2021
18 days early
2020
26 days late
2019
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 4 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · full…
  3. Annual accounts filedfinancial year 2023 · full…

Key points

  • Caution: Among the weakest 17% on solvencysector median 36.6% · 12,724 companies 5.4% View
  • Positive: 6 profitable years in a rowprofit 2025: €80,315 6 years View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€776,775
Profit
€80,315
Solvency
5.4%
Total assets▼ 3.1%
Net result
20192025
Go to Financials

Timeline

Events
11
Since
2020
Next accounts
by 31-07-2027
  1. 21-11-2023Reappointment: LE Nhu (director)
  2. 28-08-2023Annual accounts filed
  3. 13-07-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
18-12-2018
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Pharma Petite Suisse

What is the company number of Pharma Petite Suisse?
0715.975.212. In Belgium the VAT number is the company number with BE in front: BE 0715.975.212.
Where is Pharma Petite Suisse based?
The registered office is at Boondaalse Steenweg 312, 1050 Elsene.Company details
What does Pharma Petite Suisse do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Pharma Petite Suisse?
Private limited company (BV).
When was Pharma Petite Suisse founded?
On 18-12-2018.
Is Pharma Petite Suisse still active?
Yes, Pharma Petite Suisse is an active enterprise in the KBO register.
How many employees does Pharma Petite Suisse have?
On average 2.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Pharma Petite Suisse?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Pharma Petite Suisse profitable?
In financial year 2025, Pharma Petite Suisse made a profit of €80,315.
Where can I find the annual accounts of Pharma Petite Suisse?
Pharma Petite Suisse filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Pharma Petite Suisse due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Pharma Petite Suisse

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure